Загрузка...
Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels)...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544408/ https://ncbi.nlm.nih.gov/pubmed/31191823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26943 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|